Wire · opportunities
Ladera Medical Presents Full FASTEN Results Showing Rapid Hemostasis and a ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 November 2026 · Fusion42 review
Ladera Medical announced full results from the FASTEN trial showing their Large Bore Closure System achieves rapid hemostasis and a strong safety profile in patients undergoing transfemoral TAVR/TAVI, with a 98.1% freedom from major complications at 30 days and a mean time to hemostasis of 0.5 minutes.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it.
◆ ◆ The Wire takeaway
You can now offer a single-device solution for large bore femoral closure that significantly reduces complications and procedure time. This device opens a rare opportunity to capture market share in TAVR vascular closure where current methods still rely on multiple devices or implants.
◆ Coverage
2 sources · 22 Nov 2026
◆ Related on Wire
◆ Topics